Transcatheter Arterial Micro-Embolization (TAME) Using Nexsphere-F in Patients With Chronic Pain in Elbow or Wrist

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-80
SponsorNext Biomedical Co., Ltd.

About this trial

In patients with chronic elbow or wrist pain, the pain is controlled by conventional conservative therapy The pain reduction effect of Nexsphere-F embolization in patients who need additional treatment It is intended to demonstrate safety.

Eligibility criteria

Qualifiers

Those aged 19 to 80

Anyone who can provide a consent form

A person with a life expectancy of at least 12 months

Those who have not responded or failed in preservation treatment for at least three months(e.g. NSAIDS/physical therapy/steroidal joint injections, etc.)

Disqualifiers

Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain

Chronic Renal Insufficiency(Serum creatinine > 2mg/dL)

allergy to iodide contrast agents that do not respond to steroids

Those with acute infection or malignancy

Trial design

Treatments tested in this trial

  • Transcatheter Arterial Micro-Embolization

Treatment groups

38 Participants
are divided into 1 treatment group

Sponsors and collaborators